Sandbox: nima: Difference between revisions

Jump to navigation Jump to search
Line 517: Line 517:




How To




Line 565: Line 564:




About NCBI Accesskeys




Line 626: Line 624:




Z Gastroenterol. 2005 Apr;43(4):373-8.


[Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
[Article in German]
Hass HG1, Nägele T, Seeger U, Hösl F, Gregor M, Kaiser S.
Author information




Line 642: Line 630:


Hepatic encephalopathy (HE) is a common problem in liver cirrhosis and is associated with typical changes of cerebral metabolite pattern observed by proton magnetic resonance spectroscopy (MRS).
Hepatic encephalopathy (HE) is a common problem in liver cirrhosis and is associated with typical changes of cerebral metabolite pattern observed by proton magnetic resonance spectroscopy (MRS).
LinkOut - more resources
Supplemental Content
Full text links
Icon for Georg Thieme Verlag Stuttgart, New York 
Save items
Add to Favorites
View more options
Similar articles
Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
[Am J Gastroenterol. 1999]
Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.
[Hepatology. 1997]
Clinical correlation of neuropsychological tests with 1H magnetic resonance spectroscopy in hepatic encephalopathy.
[Psychosom Med. 1998]
Review Cerebral changes in hepatic encephalopathy.
[J Gastroenterol Hepatol. 1998]
Review A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment.
[Arq Gastroenterol. 2009]
See reviews...
See all...
Related information
MedGen
PubChem Compound
PubChem Compound (MeSH Keyword)
PubChem Substance
Recent Activity
You are here: NCBI > Literature > PubMed
Support Center 
Simple NCBI Directory
Getting Started
NCBI Education
NCBI Help Manual
NCBI Handbook
Training & Tutorials
Submit Data
Resources
Chemicals & Bioassays
Data & Software
DNA & RNA
Domains & Structures
Genes & Expression
Genetics & Medicine
Genomes & Maps
Homology
Literature
Proteins
Sequence Analysis
Taxonomy
Variation
Popular
PubMed
Bookshelf
PubMed Central
BLAST
Nucleotide
Genome
SNP
Gene
Protein
PubChem
Featured
Genetic Testing Registry
GenBank
Reference Sequences
Gene Expression Omnibus
Genome Data Viewer
Human Genome
Mouse Genome
Influenza Virus
Primer-BLAST
Sequence Read Archive
NCBI Information
About NCBI
Research at NCBI
NCBI News & Blog
NCBI FTP Site
NCBI on Facebook
NCBI on Twitter
NCBI on YouTube
Privacy Policy
NLM  NIH  DHHS  USA.gov 
National Center forBiotechnology Information,  U.S. National Library of Medicine
8600 Rockville Pike, Bethesda MD, 20894 USA
Policies and Guidelines | Contact


===Less Common Symptoms===
===Less Common Symptoms===

Revision as of 19:37, 15 November 2018

Overview

The majority of patients with Hepatic encephalopathy are asymptomatic.[1]

OR

The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].

History and Symptoms

Hepatic encephalopathy or portosystemic encephalopathy is a syndrome of largely reversible impairment of brain function occurring in patients with acute or chronic liver failure or when the liver is bypassed by portosystemic shunts.[2]

  • The hallmark of Hepatic Encephalopathy is . A positive history of Alcohol use and Viral Hepatitis is suggestive of Hepatitis. The most common symptoms of Hepatic encephalopathy include cognitive impairment, personality changes and change in consciousness. *Symptoms of Hepatic Encephalopathy include cognitive impairment, personality changes , and coma.

History

Patients with Hepatic Encephalopathy may have a positive history of:

  • Viral Hepatitis
  • Chronic alcohol use
  • History of drug and toxin use


  • [History finding 2]
  • [History finding 3]

Common Symptoms

Common symptoms of hepatic encephalopathy include:[3]


  • Memory impairment
  • Personality changes
  • Coma
  • Jaundice












































































































































































































































































































Hepatic encephalopathy (HE) is a common problem in liver cirrhosis and is associated with typical changes of cerebral metabolite pattern observed by proton magnetic resonance spectroscopy (MRS).

Less Common Symptoms

Less common symptoms of [disease name] include

  • [Symptom 2]
  • [Symptom 3]

References

  1. Jeong JH, Kim DK, Lee NS, Jeong YG, Kim HW, Kim JS, Han SY (2018). "Neuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction". ASN Neuro. 10: 1759091418810583. doi:10.1177/1759091418810583. PMID 30428281.
  2. Schulz C, Schütte K, Vilchez-Vargas R, Vasapolli R, Malfertheiner P (November 2018). "Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy". Dig Dis: 1–9. doi:10.1159/000494216. PMID 30428474.
  3. . PMID 30427626. Missing or empty |title= (help)

Template:WH Template:WS